Sandu Pharmaceuticals standalone net profit rises 75.00% in the December 2025 quarter
Sales rise 2.12% to Rs 18.76 crore
Net profit of Sandu Pharmaceuticals rose 75.00% to Rs 0.98 crore in the quarter ended December 2025 as against Rs 0.56 crore during the previous quarter ended December 2024. Sales rose 2.12% to Rs 18.76 crore in the quarter ended December 2025 as against Rs 18.37 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var.Sales18.7618.37 2 OPM %5.605.44 -PBDT1.030.99 4 PBT0.860.80 8 NP0.980.56 75Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content